ALVOW Alvotech - Fundamental Analysis
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
The stock trades at a negative book value, which is fundamentally unsound. Without a viable valuation metric, the current price of $0.33 cannot be justified by traditional value frameworks.
- Positive gross margin
- Negative Price/Book (-0.56)
- No Graham Number or intrinsic value available
- No P/E, PEG, or EV multiples for valuation
Growth is present on the top line, but without profitability or cash conversion, future prospects remain speculative and unproven.
- 10.6% YoY revenue growth
- No earnings growth data
- No free cash flow or operating cash flow metrics
- No forward guidance or analyst estimates
The 10% gains across 1M, 6M, 1Y, 3Y, and 5Y periods appear to be a data anomaly or misreporting, as the 52-week range is flat.
- Consistent 10% price appreciation across all timeframes
- 52-week high and low are identical ($0.33), indicating no price volatility or momentum
- No historical trend in key financials beyond revenue
The Piotroski F-Score of 2 is a major red flag, indicating poor financial health. The lack of an Altman Z-Score prevents formal distress assessment, but the combination of negative operating margin and low quick ratio suggests high risk.
- Current ratio of 1.42
- Piotroski F-Score of 2/9 (extremely weak)
- Operating margin of -2.62%
- Quick ratio of 0.54 (below 1.0, indicating liquidity strain)
- No Altman Z-Score available, raising distress risk
The company does not pay dividends, and there is no indication of any income-generating policy.
- Dividend yield and payout ratio are not available
- Dividend strength is 0/100
- No history of dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ALVOW and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ALVOW
Alvotech
Primary
|
+10.0% | +10.0% | +10.0% | +10.0% | +10.0% | +10.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Past News Coverage
Recent headlines mentioning ALVOW from our newsroom.